About eQuantX

Scanning the healthcare ecosystem with our country-specific key performance indicators (KPIs) and tracking the latest developments, we assist our clients in gathering vital insights to customize their strategies, comprehend market dynamics, and enhance product access and success

Extensive expertise in the oncology space, providing clients with tailored solutions for this specialized area. We have delivered highly quality informative outcomes to our global pharma clients on different oncology indications including Breast cancers, NSCLS & Lungs Cancer, Gastric cancers and more

Supporting big, mid cap and small pharma companies working in rare and ultra-rare indications with sales and patient based forecasting, epidemiology research and market assessment, primary market research (kol/ expert interview), competitive intelligence and pipeline assessment

eQuantX delivers proven, measurable outcomes by creating integrative and sustainable solutions in functional areas pertaining to drug value and pricing, health plan and payer engagement strategy, benefit design, patient accessibility and affordability, and market access strategy focusing on cell and gene therapies

We worked on multiple projects on Biosimilars, gaining insight into points for differentiating your product from competitor biosimilars and/or the reference product. Supported assignments in market risks and opportunity assessments, evidence generation planning, and cost-effectiveness and budget impact modeling in Biosimilars

Specialize in providing uniquely customized solutions to empower medical technology innovators in bringing new products to market by conducting primary market research, business development support, and product requirement discovery, all with the goal of accelerating market adoption and driving sales growth

Our patient surveys focus on patient journey, customer understanding, disease burden, treatment landscape, need-gap analysis, acceptability of treatment services and test of concepts for newly developed medicine or med technology. Our solutions propose quantitative and qualitative surveys, test of concepts and quick surveys via eGlobalPMR platform

Helping clients in developing and implementing digital health strategies around the use of disruptive technologies i.e. cloud, mobile, social media, analytics and automation. This will enhance the connectivity between pharmaceutical companies, their networks, and patients, with the goal of improving their operations and the quality of their products and services, reducing operational costs, and generating insights that promote better patient care

Our competitive intelligence team is a unique blend of domain knowledge and technical expertise. With hundreds of years of combined experience, we cover a wide range of therapy areas to ensure your competitive edge by analyzing clients, distributors, technology, economics, competitors, and more to keep you ahead in a dynamic business environment

Our forecasters create diverse scenarios, considering factors like competitor approvals, differentiation levels, and timing. We use modern forecasting tools that are a time-saver, allowing for data sharing across patient segments and modeling the patient journey through diagnosis, treatments, and outcomes. This provide an understanding of disease incidence at different stages, patient progression, and potential drop-off points in therapy, enhancing accuracy. Additionally, we incorporate real-world data into our models and perform in-depth analysis using analogue products for enhanced insights

Integrating commercial insights into both clinical and regulatory phases, we provide pharma companies with the tools to build a robust market access strategy. Early engagement with HTAs, payers, clinicians, and technical experts allows us to gain profound insights into their expectations, budget considerations, and price sensitivities

These models serve as invaluable tools for our clients, offering a deeper understanding of a drug's quantitative value and its projected profitability. They achieve this by integrating revenue and cost forecasts, drawing insights from a wide array of public and proprietary data sources

Our comprehensive medical conference coverage includes an event planner, at-conference support, photo and file-sharing tools, and a detailed report on clinical and commercial key takeaways. Our approach to conference coverage is flexible and tailored, allowing us to gather both primary and secondary intelligence effectively. We leverage our eConferTM platform to assist our clients in swiftly creating precise conference plans and sharing the impact of each event

With our unique eGlobal PMR platform we conduct surveys, interviews, and focus groups with HCPs, KOLs, Payers, customers, industry experts, suppliers, and employees to gather firsthand insights. This helps uncover customer preferences, pain points, and emerging trends

Our dedicated in-house team of HEOR consultants, health economists, evidence review analysts, and statisticians collaborates to construct a compelling evidence base and present data in a manner that truly resonates with reimbursement agencies and local payers, empowering you to build a robust evidence foundation and enhance your product's value proposition effectively